215 related articles for article (PubMed ID: 26585114)
1. Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk.
Ertas R; Orscelik O; Kartal D; Dogan A; Ertas SK; Aydogdu EG; Ascioglu O; Borlu M
Blood Press; 2016 Jun; 25(3):141-8. PubMed ID: 26585114
[TBL] [Abstract][Full Text] [Related]
2. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study.
Arias-Santiago S; Gutiérrez-Salmerón MT; Castellote-Caballero L; Buendía-Eisman A; Naranjo-Sintes R
J Am Acad Dermatol; 2010 Sep; 63(3):420-9. PubMed ID: 20619491
[TBL] [Abstract][Full Text] [Related]
3. Is androgenetic alopecia a risk for atherosclerosis?
Dogramaci AC; Balci DD; Balci A; Karazincir S; Savas N; Topaloglu C; Yalcin F
J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):673-7. PubMed ID: 19250324
[TBL] [Abstract][Full Text] [Related]
4. Androgenetic alopecia is associated with increased arterial stiffness in asymptomatic young adults.
Agac MT; Bektas H; Korkmaz L; Cetin M; Erkan H; Gurbak I; Hatem E; Celik S
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):26-30. PubMed ID: 24628808
[TBL] [Abstract][Full Text] [Related]
5. [Male androgenetic alopecia and cardiovascular risk factors: A case-control study].
Arias-Santiago S; Gutiérrez-Salmerón MT; Castellote-Caballero L; Buendía-Eisman A; Naranjo-Sintes R
Actas Dermosifiliogr; 2010 Apr; 101(3):248-56. PubMed ID: 20398601
[TBL] [Abstract][Full Text] [Related]
6. Circulating and/or cutaneous irisin resistance: A novel link among androgenetic alopecia, comorbid metabolic syndrome and cardiovascular risks.
Dawoud NM; Dawoud MM; El Hefnawy SM; Abdellatif HA; Abdellatif NH; Gaafar SS; Seleit I
J Cosmet Dermatol; 2023 Sep; 22(9):2584-2597. PubMed ID: 37128821
[TBL] [Abstract][Full Text] [Related]
7. A study on relationship between androgenetic alopecia and cardiovascular risk using high sensitivity C-reactive protein and galectin-3 in men with early onset baldness.
Sözen M; Baldane S; Abusoglu S; Kebapcılar L; Kebapcılar A; Tunçez Akyürek F; Ünlü A; İpekci SH
Biomarkers; 2022 Feb; 27(1):71-78. PubMed ID: 34852684
[TBL] [Abstract][Full Text] [Related]
8. Androgenetic alopecia and insulin resistance in young men.
González-González JG; Mancillas-Adame LG; Fernández-Reyes M; Gómez-Flores M; Lavalle-González FJ; Ocampo-Candiani J; Villarreal-Pérez JZ
Clin Endocrinol (Oxf); 2009 Oct; 71(4):494-9. PubMed ID: 19094069
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory markers and Lp(a) levels as cardiovascular risk factors in androgenetic alopecia.
Vayá A; Sarnago A; Ricart JM; López V; Martínez-Triguero ML; Laiz B
Clin Hemorheol Microcirc; 2015; 61(3):471-7. PubMed ID: 25536913
[TBL] [Abstract][Full Text] [Related]
10. Clinical and metabolic characteristics of males with early-onset androgenetic alopecia.
Vinay K; Bhattachajee R; Bishnoi A; Kaushik A; Sachdeva N; Pal A; Narang T; Dogra S
Indian J Dermatol Venereol Leprol; 2023; 89(4):530-535. PubMed ID: 36688892
[TBL] [Abstract][Full Text] [Related]
11. Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years.
Descamps V; Mahé E; Maccari F; Begon E; Barthelemy H; Reguiai Z; Bénéton N; Estève E; Chaby G; Ruer-Mulard M; Steiner HG; Thomas-Beaulieu D; Avenel-Audran M; Goujon-Henry C; Sigal ML; Ezzedine K; Beauchet A;
Eur J Dermatol; 2014; 24(3):356-60. PubMed ID: 24979347
[TBL] [Abstract][Full Text] [Related]
12. Early onset of androgenetic alopecia associated with early severe coronary heart disease: a population-based, case-control study.
Matilainen VA; Mäkinen PK; Keinänen-Kiukaanniemi SM
J Cardiovasc Risk; 2001 Jun; 8(3):147-51. PubMed ID: 11455846
[TBL] [Abstract][Full Text] [Related]
13. Association of early-onset androgenetic alopecia and metabolic syndrome in Thai men: a case-control study.
Pengsalae N; Tanglertsampan C; Phichawong T; Lee S
J Med Assoc Thai; 2013 Aug; 96(8):947-51. PubMed ID: 23991602
[TBL] [Abstract][Full Text] [Related]
14. The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia.
Mumcuoglu C; Ekmekci TR; Ucak S
Eur J Dermatol; 2011; 21(1):79-82. PubMed ID: 21224180
[TBL] [Abstract][Full Text] [Related]
15. Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study.
Yang CC; Hsieh FN; Lin LY; Hsu CK; Sheu HM; Chen W
J Am Acad Dermatol; 2014 Feb; 70(2):297-302.e1. PubMed ID: 24184140
[TBL] [Abstract][Full Text] [Related]
16. Androgenetic alopecia: Traditional cardiovascular risk factors, metabolic syndrome, and component traits among Nigerian adults.
Oiwoh SO; Akinboro AO; Olayemi O; Salawu AA; Olasode OA; Onayemi EO
Niger J Clin Pract; 2023 Apr; 26(4):463-469. PubMed ID: 37203111
[TBL] [Abstract][Full Text] [Related]
17. Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
Arias-Santiago S; Arrabal-Polo MA; Buendía-Eisman A; Arrabal-Martín M; Gutiérrez-Salmerón MT; Girón-Prieto MS; Jimenez-Pacheco A; Calonje JE; Naranjo-Sintes R; Zuluaga-Gomez A; Serrano Ortega S
J Am Acad Dermatol; 2012 Mar; 66(3):401-8. PubMed ID: 21835498
[TBL] [Abstract][Full Text] [Related]
18. The association of insulin resistance and metabolic syndrome in early androgenetic alopecia.
Acibucu F; Kayatas M; Candan F
Singapore Med J; 2010 Dec; 51(12):931-6. PubMed ID: 21221497
[TBL] [Abstract][Full Text] [Related]
19. Gender-specific association of androgenetic alopecia with metabolic syndrome in a middle-aged Korean population.
Yi SM; Son SW; Lee KG; Kim SH; Lee SK; Cho ER; Kim IH; Shin C
Br J Dermatol; 2012 Aug; 167(2):306-13. PubMed ID: 22486172
[TBL] [Abstract][Full Text] [Related]
20. Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey.
Su LH; Chen TH
Br J Dermatol; 2010 Aug; 163(2):371-7. PubMed ID: 20426781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
